oncnursingnews1d
JOAN SUCH LOCKHART, PHD, RN, AOCN, CNE, ANEF, FAAN
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews1d
Top 5 Articles in 2024 for Oncology APPs and Nurses
Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...
oncnursingnews3d
Katie Goodman, RN, BSN, CCRP
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews3d
Angee Kilmer, BSN, RN-BC
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews3d
Pattie Jakel, MN, RN, AOCN
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews3d
Marlon Garzo Saria, PhD, RN, AOCNS, FAAN
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews4d
Toby Bressler, PhD, RN, OCN
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews4d
MANJULATA EVATT, DNP, RN, CMSRN
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews4d
Treatment Selection and Sequencing Strategies in HER2+ Metastatic Breast Cancer
Chemo Should be Tailored to Decrease Neuropathy in Black Patients ...
oncnursingnews5d
Paige Soleimani, LMSW
ASC4FIRST Trial Supports Asciminib With Secondary End Points in CML ...
oncnursingnews5d
Bernardo L. Rapoport, MD
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews5d
Managing Adverse Events with CAR T-Cell Therapy: Best Practices for Myeloma Care Teams
Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...